EcoDrugPlus

Somatostatin Receptor 2

Ensembl ID : ENSMZEG00005006519
Gene Symbol: SSTR2
1 Cross references
191 Possible Orthologues:

Somatostatin Receptor 5

Ensembl ID : ENSMZEG00005023299
Gene Symbol: SSTR5
3 Cross references
188 Possible Orthologues:

Somatostatin Receptor Type 5

Ensembl ID : ENSMZEG00005006017
Gene Symbol: LOC101463923
2 Cross references
178 Possible Orthologues:

Sphingosine Kinase 2

Ensembl ID : ENSMZEG00005016265
Gene Symbol: SPHK2
2 Cross references
200 Possible Orthologues:

Sphingosine-1-Phosphate Receptor 1

Ensembl ID : ENSMZEG00005017898
Gene Symbol: S1PR1
3 Cross references
200 Possible Orthologues:

Spleen Associated Tyrosine Kinase

Ensembl ID : ENSMZEG00005010985
Gene Symbol: SYK
3 Cross references
200 Possible Orthologues:

Steroid 17-Alpha-Hydroxylase/17,20 Lyase

Ensembl ID : ENSMZEG00005028242
Gene Symbol: LOC101477086
3 Cross references
209 Possible Orthologues:

Sterol O-Acyltransferase 1

Ensembl ID : ENSMZEG00005004172
Gene Symbol: SOAT1
3 Cross references
210 Possible Orthologues:

Tachykinin Receptor 1

Ensembl ID : ENSMZEG00005004559
Gene Symbol: TACR1
3 Cross references
195 Possible Orthologues:

Tachykinin Receptor 2

Ensembl ID : ENSMZEG00005011458
Gene Symbol: TACR2
3 Cross references
199 Possible Orthologues:

Tachykinin Receptor 3

Ensembl ID : ENSMZEG00005022642
Gene Symbol: TACR3
4 Cross references
208 Possible Orthologues:

Telomerase Reverse Transcriptase

Ensembl ID : ENSMZEG00005011297
Gene Symbol: TERT
3 Cross references
189 Possible Orthologues:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).